CIRCULOGENE has laboratories in Birmingham, AL and Pensacola, FL. Our CAP and CLIA-certified, laboratory-developed tests implements stringent pre-analytical validation to ensure consistent, quality, data acquisition.
Our liquid biopsy services leverage proven technology and provide a noninvasive, cost-effective solution for high-sensitivity detection across a variety of samples. Using a minimal-volume of blood, our unique technology provides unprecedented information with an up-to-date clinical status in a more complete, accurate and timely fashion.
Molecular Cancer Diagnostics
CIRCULOGENE’s molecular cancer diagnostics services leverage proven technology and provide a noninvasive and cost-effective solution for high-sensitivity monitoring. Our unique technology uses both next-generation sequencing (NGS) and polymerase chain reaction (PCR) to provide unprecedented, best-in-class, tumor monitoring information with an up-to-date clinical status in a more complete, accurate, timely, less expensive, and less invasive fashion.
The College of American Pathologists
CAP NUMBER: 9373166 Clinical Laboratory Improvement Amendments (CLIA)
CLIA NUMBER: 01D2101075